Freedom (FRHC) had the highest return between April 1, 2017 and September 30, 2017 by a mid-cap US stock, returning 627.3%.
| ASSET | DATE | % RETURN |
|---|---|---|
Freedom (FRHC) | 4/1/2017 - 9/30/2017 | 627.27% |
Leonardo DRS, Inc Common Stock (DRS) | 4/1/2017 - 9/30/2017 | 204.46% |
Madrigal Pharmaceuticals (MDGL) | 4/1/2017 - 9/30/2017 | 193.41% |
Arrowhead Pharmaceuticals (ARWR) | 4/1/2017 - 9/30/2017 | 132.8% |
Vericel Corp Ord (VCEL) | 4/1/2017 - 9/30/2017 | 114.29% |
Amicus Therapeutics (FOLD) | 4/1/2017 - 9/30/2017 | 110.32% |
PTC Therapeutics (PTCT) | 4/1/2017 - 9/30/2017 | 103.98% |
RadNet (RDNT) | 4/1/2017 - 9/30/2017 | 99.14% |
EXACT Sciences (EXAS) | 4/1/2017 - 9/30/2017 | 98.4% |
Quidel (QDEL) | 4/1/2017 - 9/30/2017 | 93.73% |
Light & Wonder (LNW) | 4/1/2017 - 9/30/2017 | 93.05% |
AeroVironment (AVAV) | 4/1/2017 - 9/30/2017 | 91.44% |
TAL Education (TAL) | 4/1/2017 - 9/30/2017 | 90.53% |
Appian (APPN) | 4/1/2017 - 9/30/2017 | 89.73% |
Autohome (ATHM) | 4/1/2017 - 9/30/2017 | 89.47% |
Weibo (WB) | 4/1/2017 - 9/30/2017 | 88.49% |
YY Inc Class A (YY) | 4/1/2017 - 9/30/2017 | 87.71% |
Trupanion (TRUP) | 4/1/2017 - 9/30/2017 | 85.59% |
Floor & Decor (FND) | 4/1/2017 - 9/30/2017 | 85.38% |
Appfolio (APPF) | 4/1/2017 - 9/30/2017 | 77.59% |
Corcept Therapeutics (CORT) | 4/1/2017 - 9/30/2017 | 75.45% |
Blueprint Medicines (BPMC) | 4/1/2017 - 9/30/2017 | 73.87% |
Kadant (KAI) | 4/1/2017 - 9/30/2017 | 67.53% |
Wayfair (W) | 4/1/2017 - 9/30/2017 | 66.91% |
Kratos Defense & Security Solutions (KTOS) | 4/1/2017 - 9/30/2017 | 66.2% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
